Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells
Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the unde...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 118; no. 21; pp. 2156 - 2165 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
18.11.2008
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-7322 1524-4539 1524-4539 |
DOI | 10.1161/CIRCULATIONAHA.108.787200 |
Cover
Abstract | Background—
Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.
Methods and Results—
Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum–induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.
Conclusion—
Scleroderma serum–induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients. |
---|---|
AbstractList | Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.
Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.
Scleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients. Background— Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was. Methods and Results— Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum–induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects. Conclusion— Scleroderma serum–induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients. Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.BACKGROUNDEndothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was.Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.METHODS AND RESULTSCirculating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.Scleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.CONCLUSIONSScleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients. |
Author | Zhu, Shoukang Povsic, Thomas J. Dong, Chunming Yan, Bin Tapson, Victor Evans, Sarah Goldschmidt-Clermont, Pascal J. |
AuthorAffiliation | Miller School of Medicine, University of Miami, Miami, FL 33101 Department of Medicine, Duke University Medical Center, Durham, NC 27710 |
AuthorAffiliation_xml | – name: Department of Medicine, Duke University Medical Center, Durham, NC 27710 – name: Miller School of Medicine, University of Miami, Miami, FL 33101 |
Author_xml | – sequence: 1 givenname: Shoukang surname: Zhu fullname: Zhu, Shoukang organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 2 givenname: Sarah surname: Evans fullname: Evans, Sarah organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 3 givenname: Bin surname: Yan fullname: Yan, Bin organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 4 givenname: Thomas J. surname: Povsic fullname: Povsic, Thomas J. organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 5 givenname: Victor surname: Tapson fullname: Tapson, Victor organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 6 givenname: Pascal J. surname: Goldschmidt-Clermont fullname: Goldschmidt-Clermont, Pascal J. organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) – sequence: 7 givenname: Chunming surname: Dong fullname: Dong, Chunming organization: From the Miller School of Medicine, University of Miami, Miami, Fla (S.Z., P.J.G.-C., C.D.), and Department of Medicine, Duke University Medical Center, Durham, NC (S.E., B.Y., T.J.P., V.T.) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18981303$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1DAUhS1URKeFV0Bmwy6Df8aJswFNo5aONDConUrsIse-mRoSO9gJUneIV-ANeRJcpvyUFSv72t8959rnCB047wChZ5TMKc3pi2p1UV2tl9vV5u3yfDmnRM4LWTBCHqAZFWyRLQQvD9CMEFJmBWfsEB3F-CGVOS_EI3RIZSkpJ3yGvm6DclEHO4zWO9XhC9hNnbotsG_xie1xc4PPNu83XGHlDF5-HPEbMFaNEPGl7iB4A6FX-BLC1H__8m3lzKQhgYMfRh9txNbhU2f8eA2dTQ7vgt-Bs6MPuIKui4_Rw1Z1EZ7crcfo6ux0W51n683rVbVcZ1oQMWYN47lkijJWiDzn1GjJSAFUGqEEKQk0SuYLk3aiBQKFEZwLxiVrG61zaPgxernXHaamB6PBjUF19RBsr8JN7ZWt7984e13v_OeaF7QklCSB53cCwX-aII51b6NOT1AO_BTrvJQkDckS-PRvp98Wv749AeUe0MHHGKD9g5D6NuL6fsTpWNb7iFPvq396tR1_BpaGtt1_KPwAjqOyQg |
CitedBy_id | crossref_primary_10_1183_09059180_00003214 crossref_primary_10_1136_annrheumdis_2011_200713 crossref_primary_10_1182_blood_2013_10_530964 crossref_primary_10_3390_ijms241814385 crossref_primary_10_1002_art_24921 crossref_primary_10_1002_cbin_11016 crossref_primary_10_1038_nrrheum_2009_81 crossref_primary_10_1016_j_jid_2016_08_027 crossref_primary_10_1016_j_revmed_2019_05_016 crossref_primary_10_1016_j_vph_2015_05_015 crossref_primary_10_4049_jimmunol_2000971 crossref_primary_10_1016_j_mvr_2015_01_004 crossref_primary_10_1371_journal_pone_0101703 crossref_primary_10_1097_BOR_0b013e3283328098 crossref_primary_10_1002_jcp_24938 crossref_primary_10_1016_j_cellsig_2018_08_009 crossref_primary_10_1155_2014_972043 crossref_primary_10_1007_s11883_012_0244_1 crossref_primary_10_3389_fimmu_2018_01383 crossref_primary_10_1007_s12015_023_10617_y crossref_primary_10_1155_2010_362868 crossref_primary_10_1158_0008_5472_CAN_10_3253 crossref_primary_10_4049_jimmunol_1601968 crossref_primary_10_3389_fimmu_2015_00272 crossref_primary_10_1016_j_autrev_2024_103540 crossref_primary_10_1111_cpr_12962 crossref_primary_10_1002_art_40505 crossref_primary_10_1016_j_autrev_2017_05_024 crossref_primary_10_1074_jbc_M111_221697 crossref_primary_10_1111_1756_185X_12487 crossref_primary_10_1016_j_ijbiomac_2018_05_174 crossref_primary_10_3390_ph16060906 crossref_primary_10_1186_s13075_017_1271_7 crossref_primary_10_1038_nrrheum_2010_102 crossref_primary_10_1016_j_mvr_2013_07_009 crossref_primary_10_1038_s41392_018_0026_5 crossref_primary_10_1186_ar3180 crossref_primary_10_1002_jcb_28801 crossref_primary_10_1186_ar3069 crossref_primary_10_5301_jsrd_5000217 crossref_primary_10_1007_s12031_013_0111_8 crossref_primary_10_1155_2011_495792 crossref_primary_10_1093_rheumatology_kev399 crossref_primary_10_1371_journal_pone_0031226 crossref_primary_10_1002_art_30361 crossref_primary_10_1186_s12882_015_0064_y crossref_primary_10_1002_cbin_11887 crossref_primary_10_3390_biomedicines9070847 crossref_primary_10_1159_000444517 crossref_primary_10_1111_j_1471_4159_2009_06043_x crossref_primary_10_1111_j_1582_4934_2010_01027_x crossref_primary_10_2174_1871520620666200627204857 crossref_primary_10_3899_jrheum_091346 crossref_primary_10_1016_j_autrev_2011_04_016 crossref_primary_10_1016_j_jsbmb_2017_07_005 crossref_primary_10_1155_2017_8208065 crossref_primary_10_1007_s10495_015_1126_0 |
Cites_doi | 10.1056/NEJMoa022287 10.1161/01.cir.0000082924.75945.48 10.1007/s10067-004-0987-3 10.1371/journal.pmed.0020354 10.1136/ard.2007.082131 10.1096/fj.04-2727fje 10.1002/art.1780230510 10.1186/ar2165 10.1016/S0140-6736(04)16864-5 10.1002/art.22035 10.1016/j.ejphar.2007.01.045 10.1126/science.275.5302.964 10.2217/14796694.2.1.83 10.1007/s11926-008-0031-8 10.1002/art.21952 10.1161/01.atv.0000114236.77009.06 10.1016/j.radonc.2006.07.021 10.1074/jbc.M304736200 10.1002/art.11310 10.1007/s12016-007-8009-2 10.1016/S0140-6736(04)16853-0 10.1038/sj.onc.1208421 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1161/CIRCULATIONAHA.108.787200 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | 2165 |
ExternalDocumentID | PMC3719010 18981303 10_1161_CIRCULATIONAHA_108_787200 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIA NIH HHS grantid: AG023073 – fundername: NIA NIH HHS grantid: R01 AG023073 – fundername: National Institute on Aging : NIA grantid: R01 AG023073 || AG |
GroupedDBID | --- .-D .3C .55 .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAEJM AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AARTV AASOK AAUEB AAWTL AAXQO AAYOK AAYXX ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABXVJ ABZAD ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACOAL ACRKK ACWDW ACWRI ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFCHL AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJZMW ALKUP ALMA_UNASSIGNED_HOLDINGS AMJPA AMNEI ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C1A C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GX1 H0~ H13 HZ~ H~9 IKREB IKYAY IN~ J5H JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B M18 N9A NEJ N~7 N~B O9- OAG OAH OBH OCB OCUKA ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RLZ S4R S4S T8P TEORI TR2 UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ZZMQN ~H1 CGR CUY CVF ECM EIF NPM 7X8 ADKSD 5PM |
ID | FETCH-LOGICAL-c505t-b23682a122756631dc8207e18d5a5090eba864d0905fe0e7d53352382fbcc6eb3 |
ISSN | 0009-7322 1524-4539 |
IngestDate | Thu Aug 21 13:34:11 EDT 2025 Sun Sep 28 01:33:36 EDT 2025 Mon Jul 21 06:05:55 EDT 2025 Thu Apr 24 22:56:24 EDT 2025 Tue Jul 01 02:05:32 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c505t-b23682a122756631dc8207e18d5a5090eba864d0905fe0e7d53352382fbcc6eb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18981303 |
PQID | 69802362 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3719010 proquest_miscellaneous_69802362 pubmed_primary_18981303 crossref_primary_10_1161_CIRCULATIONAHA_108_787200 crossref_citationtrail_10_1161_CIRCULATIONAHA_108_787200 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-11-18 |
PublicationDateYYYYMMDD | 2008-11-18 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-11-18 day: 18 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationTitleAlternate | Circulation |
PublicationYear | 2008 |
References | e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 (e_1_3_2_10_2) 1988; 15 e_1_3_2_1_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_22_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_23_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 14613262 - Arthritis Rheum. 2003 Nov;48(11):3023-30 15349798 - Clin Rheumatol. 2005 Apr;24(2):111-6 16250671 - PLoS Med. 2005 Dec;2(12):e354 17767740 - Arthritis Res Ther. 2007;9 Suppl 2:S2 16868984 - Arthritis Rheum. 2006 Aug;54(8):2605-15 12860902 - Circulation. 2003 Jul 29;108(4):457-63 12584367 - N Engl J Med. 2003 Feb 13;348(7):593-600 27161125 - Acta Haematol. 2016;136(2):65-70 15313361 - Lancet. 2004 Aug 14-20;364(9434):603-10 16802364 - Arthritis Rheum. 2006 Jul;54(7):2250-62 15688014 - Oncogene. 2005 Mar 31;24(14):2317-29 17320859 - Eur J Pharmacol. 2007 May 7;562(1-2):111-8 16556075 - Future Oncol. 2006 Feb;2(1):83-9 18064573 - Clin Rev Allergy Immunol. 2007 Oct;33(1-2):107-12 15313340 - Lancet. 2004 Aug 14-20;364(9434):561-2 14551207 - J Biol Chem. 2004 Jan 9;279(2):1513-25 16916558 - Radiother Oncol. 2006 Aug;80(2):199-206 18174219 - Ann Rheum Dis. 2008 Oct;67(10):1455-60 14699017 - Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):288-93 18638425 - Curr Rheumatol Rep. 2008 Jul;10(3):183-8 7378088 - Arthritis Rheum. 1980 May;23(5):581-90 9020076 - Science. 1997 Feb 14;275(5302):964-7 15824087 - FASEB J. 2005 Jun;19(8):974-6 3361530 - J Rheumatol. 1988 Feb;15(2):202-5 |
References_xml | – ident: e_1_3_2_11_2 doi: 10.1056/NEJMoa022287 – ident: e_1_3_2_19_2 doi: 10.1161/01.cir.0000082924.75945.48 – ident: e_1_3_2_4_2 doi: 10.1007/s10067-004-0987-3 – ident: e_1_3_2_5_2 doi: 10.1371/journal.pmed.0020354 – ident: e_1_3_2_20_2 doi: 10.1136/ard.2007.082131 – ident: e_1_3_2_15_2 doi: 10.1096/fj.04-2727fje – ident: e_1_3_2_9_2 doi: 10.1002/art.1780230510 – ident: e_1_3_2_17_2 doi: 10.1186/ar2165 – ident: e_1_3_2_2_2 doi: 10.1016/S0140-6736(04)16864-5 – ident: e_1_3_2_8_2 doi: 10.1002/art.22035 – ident: e_1_3_2_12_2 doi: 10.1016/j.ejphar.2007.01.045 – ident: e_1_3_2_18_2 doi: 10.1126/science.275.5302.964 – ident: e_1_3_2_6_2 doi: 10.2217/14796694.2.1.83 – ident: e_1_3_2_13_2 doi: 10.1007/s11926-008-0031-8 – ident: e_1_3_2_22_2 doi: 10.1002/art.21952 – ident: e_1_3_2_21_2 doi: 10.1161/01.atv.0000114236.77009.06 – ident: e_1_3_2_14_2 doi: 10.1016/j.radonc.2006.07.021 – ident: e_1_3_2_16_2 doi: 10.1074/jbc.M304736200 – ident: e_1_3_2_3_2 doi: 10.1002/art.11310 – ident: e_1_3_2_1_2 doi: 10.1007/s12016-007-8009-2 – volume: 15 start-page: 202 year: 1988 ident: e_1_3_2_10_2 publication-title: J Rheumatol – ident: e_1_3_2_7_2 doi: 10.1016/S0140-6736(04)16853-0 – ident: e_1_3_2_23_2 doi: 10.1038/sj.onc.1208421 – reference: 14551207 - J Biol Chem. 2004 Jan 9;279(2):1513-25 – reference: 15349798 - Clin Rheumatol. 2005 Apr;24(2):111-6 – reference: 9020076 - Science. 1997 Feb 14;275(5302):964-7 – reference: 16802364 - Arthritis Rheum. 2006 Jul;54(7):2250-62 – reference: 12860902 - Circulation. 2003 Jul 29;108(4):457-63 – reference: 14613262 - Arthritis Rheum. 2003 Nov;48(11):3023-30 – reference: 15824087 - FASEB J. 2005 Jun;19(8):974-6 – reference: 17767740 - Arthritis Res Ther. 2007;9 Suppl 2:S2 – reference: 15313340 - Lancet. 2004 Aug 14-20;364(9434):561-2 – reference: 3361530 - J Rheumatol. 1988 Feb;15(2):202-5 – reference: 16916558 - Radiother Oncol. 2006 Aug;80(2):199-206 – reference: 27161125 - Acta Haematol. 2016;136(2):65-70 – reference: 15688014 - Oncogene. 2005 Mar 31;24(14):2317-29 – reference: 14699017 - Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):288-93 – reference: 16250671 - PLoS Med. 2005 Dec;2(12):e354 – reference: 16556075 - Future Oncol. 2006 Feb;2(1):83-9 – reference: 16868984 - Arthritis Rheum. 2006 Aug;54(8):2605-15 – reference: 17320859 - Eur J Pharmacol. 2007 May 7;562(1-2):111-8 – reference: 7378088 - Arthritis Rheum. 1980 May;23(5):581-90 – reference: 18638425 - Curr Rheumatol Rep. 2008 Jul;10(3):183-8 – reference: 12584367 - N Engl J Med. 2003 Feb 13;348(7):593-600 – reference: 18174219 - Ann Rheum Dis. 2008 Oct;67(10):1455-60 – reference: 15313361 - Lancet. 2004 Aug 14-20;364(9434):603-10 – reference: 18064573 - Clin Rev Allergy Immunol. 2007 Oct;33(1-2):107-12 |
SSID | ssj0006375 |
Score | 2.2478883 |
Snippet | Background—
Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to... Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2156 |
SubjectTerms | Adult Aged Apoptosis Apoptosis Regulatory Proteins - biosynthesis Bcl-2-Like Protein 11 Cells, Cultured Colony-Forming Units Assay - methods Endothelial Cells - metabolism Endothelial Cells - pathology Female Forkhead Box Protein O3 Forkhead Transcription Factors - metabolism Humans Immunoglobulin G - metabolism Male Membrane Proteins - biosynthesis Middle Aged Proto-Oncogene Proteins - biosynthesis Proto-Oncogene Proteins c-akt - metabolism Regeneration Scleroderma, Systemic - metabolism Scleroderma, Systemic - pathology Serum - metabolism Stem Cells - metabolism Stem Cells - pathology Transcription, Genetic Up-Regulation |
Title | Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18981303 https://www.proquest.com/docview/69802362 https://pubmed.ncbi.nlm.nih.gov/PMC3719010 |
Volume | 118 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1524-4539 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0006375 issn: 0009-7322 databaseCode: KQ8 dateStart: 19500101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1524-4539 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006375 issn: 0009-7322 databaseCode: DIK dateStart: 19500101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1524-4539 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006375 issn: 0009-7322 databaseCode: GX1 dateStart: 19500101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIlVcELQ8wnORUC-RS2yv184xjRoFSBtAiRS4WOv1hkRt7JDYSOXEX-GfMuO30yAKF8vaZL2W5_PszHjmG0JeGx4zkAVGazPR0eB8pnmGZWhcSpsxGyCdFAqfnfPBhL2bWtNG41claymOvGP5Y2ddyf9IFcZArlgl-w-SLS4KA3AO8oUjSBiON5MxbjT5a58w9H_NunGhDXiyWKJx2R9NR2ZSedXqXkRpqQgGWzdwsTV2QluKFtxtvNTAPY8xHUCswlUUIlMJ8okEPhZpXWJkHZO5FOqAdQsD_puqZdtbrGW--I4OP5WIw5d5nMRc52F8IbKNs2rT14LUn9MA7cmiAPGH8Dsgq0xuyj5s5ZELB0v46srWYBqzUjKjY7VjLNfQ5aw4r6guFG7KS359J-C4E_TefupNhimv8KCLCZXHoKFSctQt9u3zkdufDIfu-HQ6Plp907AxGX7Az7q03CK3DZtzbJLx_mNJSM_NhMu5uO198ipb_c0f166bQNf8mu303Iq9M75H7maOCu2mqLtPGio4IIfdQETh8ooe0SR1OPkmc0D2z7IMjUPycwuTtMQkDWcUMEm9K5pikgImKWCS5pikFUzSGiZpgUm6CGgFk7TEJE0w-YBM-qfj3kDLunxoEqzvCFSDyR1D6AY2IuCm7kswSm2lO74lwJptK084nPlwZs1UW9m-hWWCpmPMPCm58syHZC8IA_WYUHB-JVOmKXzmMKnrHvjCDhO-ZB64KaZoEid_8K7MKPCxE8ulm7jCXHfrMkP2XDeVWZMYxdRVygNzk0kvc-m6oLXxKYhAhfHG5R0kXuRGkzxKZV1e1Ok4aFc2iV1DQfEH5IOv_xIs5gkvvGmjdd9-8tdVn5I75fv4jOxF61g9B9s68l4k6P4N0B3QQA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcriptional+regulation+of+Bim+by+FOXO3a+and+Akt+mediates+scleroderma+serum-induced+apoptosis+in+endothelial+progenitor+cells&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Zhu%2C+Shoukang&rft.au=Evans%2C+Sarah&rft.au=Yan%2C+Bin&rft.au=Povsic%2C+Thomas+J&rft.date=2008-11-18&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=118&rft.issue=21&rft.spage=2156&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.108.787200&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |